Profile of the Enterprise
Jiuming Group is a newstyle group of big health, medical treatment and medicine, integrating research and development, production, sales, delivery, chain drugstore, pharmacy inside and outside a hospital, pharmaceutical logistics extension(mandated hospital) and medical and elderly service centers. The Group comprises subsidiaries such as Shenzhen Jiuming Pharmaceutical Co., Ltd., Guangdong Jiuming Pharmaceutical Co., Ltd., Jiuming Biotech Development Co., Ltd. (Jiuming Pharmaceutical Research Institute), Guangdong Jiuming Pharmacy Chain Co., Ltd., Medical Rehabilitation Center of Jiuming Zunyi Medical University’s The Fifth Affiliated Hospital Co., Ltd., Shenzhen Jiuming Convenience Pharmacy Co., Ltd. and Zhuhai Jiuming Special Hospital for Senile Diseases (a tertiary special hospital), etc.
Established in 2003 with a registered capital of RMB 100 million Yuan, Shenzhen Jiuming Pharmaceutical Co., Ltd. is a large enterprise specialized in the operation and whole-sale of medicines and medical apparatus. The company is running a complete range of business, which covers categories such as Chinese herbal medicines, TCM decoction pieces, Chinese patent medicine, chemical preparations, antibiotic preparations, second class psychotropic substances (preparations) and all kinds of medical apparatus products, with a superior and complete sales network covering all provinces and autonomous regions. Meanwhile, it is also the only provider of medicines and consumables for the troops of Chinese People’s Liberation Army stationed in Hong Kong and the fifth affiliated hospital of Zunyi Medical University,Zhuhai. The company’s sales amount increases at a speed of over 30% each year. The company has been honored as an “Enterprise with Highest Social Responsibility in Futian District” and a “Member Enterprise with Highest Development Potential in Futian District”. In 2014, it won a governmental financial aid program certified by Shenzhen Hightech Industrial Innovation Center. On August 3, 2015, Jiuming Pharmaceutical officially signed a cooperation agreement with the fifth affiliated hospital of Zunyi Medical University,Zhuhai to confirm the former as the only supplier of medicines and medical consumables for the latter. Jiuming Pharmaceutical officially became a private enterprise for mandated tertiary Class A hospitals and stepped into the endowment industry.
Completed and put into operation in 2010, Guangdong Jiuming Pharmaceutical Co., Ltd. is a new pharmaceutical enterprise invested by the Shenzhen headquarters in Heyuan and a national hightech enterprise with three hightech products. Occupying a land of near 50,000 ㎡, the pharmaceutical factory has a clean environment, modernized GMP workshops of 15,000 ㎡, labs of more than 3,000 ㎡, with 22 technicians, including 1 chief pharmacist, 1 senior engineer, and 11 licensed pharmacists. Its existing crude drug workshop, solid preparation workshop and Cephalosporins workshop have all passed the certification of the new edition national GMP, which are mainly producing preparations such as tablets, hard capsules, Cephalosporins hard capsules, medicines of 45 specifications, crude drugs such as soldium salicylate and desloratadine, among which Mingtuo brand desloratadine capsule is a globally exclusive type of hightech antiallergy medicine. The desloratadine crude drug, desloratadine tablet and desloratadine capsule produced by the company were certified by the Department of Science and Technology of Guangdong Province as a high-tech product. In 2014, Jiuming Pharmaceutical was certified as a national hightech enterprise and an anti-allergy engineering technology research institute of Guangdong Province. On the basis of innovative development, the company has planned a factory of crude drugs, a workshop for extraction of Chinese herbal medicine, a workshop of medical apparatus and a workshop of injection, establishing a new pharmacy production base in Heyuan and building a comprehensive vertical production structure. The company keeps developing and introducing high technologies and patented new products with a high additional value to build a new pharmaceutical industrial chain. The “key technology research and industrialization of desloratadine capsule” is an unprecedented creative technology. The program has passed the appraisal of science and technology departments. Experts of the appraisal committee unanimously believe that the fruit has filled a blank in the clinical medication of desloratadine capsule in China and reached a leading technology level at home. The program won a first prize at city level for scientific and technological progress and a third prize of Guangdong Province for scientific and technological progress respectively in 2014 and 2016. In 2016, desloratadine took the second spot among the “new medicines with highest market potential” in PharmChina in the appraisal conducted by pharmacy experts, big data collection and online voting. In recent years, the company has won strong support from party committee and government at each level. The enterprise keeps developing and growing and now has become an enterprise of Heyuan to go public as soon as possible and the first listed enterprise in the pharmacy industry of Heyuan.
Jiuming Biotech Development Co., Ltd. was established in January 2002, on the basis of which Jiuming Pharmaceutical Institute was officially opened and established in the base of Jiuming at Shiyan. Since its establishment, the Institute has insisted on a path of “independent innovation and industrial transformation”. In 2013, it developed three national second-class new medicines, successfully completed a pilot plant test, and won a first prize at the city level for scientific and technological progress, with two national invention patents and undertaking work such as packing material registration and changes, new medicine screening and reregistration. At present, on the basis of the latest technology of activated carbon absorbent mask at home and abroad, it has independently developed the globally firstever white nanometer microporous absorption PM2.5 mask and won a governmental financial aid of millions of RMB certified by Shenzhen Hightech Industrial Innovation Center. It has established cooperation with a batch of universities of the National 211 Program, kept developing and introducing patented new products with high technologies and high additional values. Utilizing a combination of medicine and equipment, it has developed related products of newtype medical apparatus, offering an important support for the building of a new pharmaceutical industrial chain and adding a new bright spot of development for the enterprise in the integration of technology, industry and trading.
The Shiyan base of Jiuming Pharmaceutical lies at No. 7, Xingye Road, the No. 3 Industrial Zone, Shilongzai, Shiyan subdistrict, Bao’an district, Shenzhen, which is a comprehensive modernized large pharmacy logistics industrial park established by Jiuming Group, integrating distribution, warehousing, logistics, training and office. Now with a warehousing area of 6,000 ㎡, several warehouse quality inspectors, maintenance workers and warehouse keepers and a strictly trained and professional team of medicine distribution, it has formed a complete medicine distribution system and a distribution network covering the whole city of Shenzhen. Meanwhile, Jiuming Bio-tech Development Co., Ltd. has opened the globally first-ever white nanometer microporous absorbent PM2.5 mask workshop at its Shiyan base. The functions of the warehouse include a cool warehouse, a normal temperature warehouse, a warehouse for prevention of tainting of odors, a warehouse of Chinese herbal medicine, a warehouse of medical apparatus, a refrigeration warehouse and a warehouse of special medicines. The warehouse are complete in facilities, and has thus won high praise from the provincial and municipal drug watchdogs and peers of the industry.
Established on March 22, 2016, Jiuming Pharmaceutical Zhuhai Base lies at No. 1, Shiqun Road, Shiqun Village, Qianwu Town, Doumen District, Zhuhai, occupying a land of 6,000 plus ㎡, with a floor area of 8,600 plus ㎡, already enabling a warehousing area of 1,800 plus ㎡. Its warehouses of medicines and medical apparatus have respectively passed the GSP certification of Guangdong and acceptance of the Food and Drug Administration of Zhuhai. The base is the main camp of the company in pursuing its strategy of expansion in Western Guangdong as well as a bridgehead for business expansion and construction, operation and management in the west of Guangdong. Meanwhile, the base is also a large pharmacy logistics distribution center integrating warehousing, transport, distribution and life guarantee. The base is mainly responsible for the company to perform its tasks of supplying and logistics of medicines, consumables and medical apparatus to mandated hospitals in the west of Guangdong (at present it has undertaken the supply and distribution for the fifth affiliated hospital of Zunyi Medical University,Zhuhai in Doumen district); it is responsible for the planning of Jiuming Medical Rehabilitation Center and expansion and construction of in-hospital pharmacies in the west of Guangdong. Meanwhile, it is responsible for the logistical supply guarantee tasks of Jiuming Medical Rehabilitation Center and is a main camp of sales of the company in the west of Guangdong. The Zhuhai base has an upright and strong leading team and workforce, which guarantees that the decisions and directions from the head office are implemented resolutely and provides strong support and guarantee for the operation and development of the base. In 2016, the annual sales amount of the base will reach millions of RMB. Looking into the future, Zhuhai base will start from the logistics of the fifth affiliated hospital of Zunyi Medical University,Zhuhai in Doumen district, Zhuhai and the construction tasks of Jiuming Medical Rehabilitation Center, build a replicable model for pharmacy logistics & distribution, integration of medical treatment and care and inhospital pharmacy and guarantee the smooth implementation of the company’s development strategy for Western Guangdong.
In 2015, Heyuan Jiuming Kangjian Pharmacy Chain Co., Ltd., a whollyowned subsidiary of Jiuming Pharmaceutical, was established, which laid down a foundation for the opening of prescription medicine sales network. In 2016, two inhospital pharmacies of Jiuming Pharmaceutical (the eighth affiliated hospital of Sun Yatsen University and the fifth affiliated hospital of Zunyi Medical University,Zhuhai) were officially opened. The inhospital pharmacies supplement the shortage medicines and temporary medicines for the pharmacies of hospitals, make it more convenient for patients to buy special medicines and temporary medicines, and thoroughly enable the patients to buy medicines from a retail pharmacy with the prescription at a zero distance. To better practice the service philosophy centered on patients and guarantee the continuity of medication for patients, supplement the shortage medicines and temporary medicines of pharmacies of hospitals and make it more convenient for patients to buy special medicines and temporary medicines, Jiuming Pharmaceutical has opened dozens of outsidehospital convenience drugstores in Longhu, Guangming, Buji, Nanshan, No. 2 Hospital of the City, Futian, Children’s Hospital and Longgang near each major hospital of the whole city. To make it convenient for the patients, Jiuming Pharmaceutical has creatively developed a WeChat business software for delivering medicine to clinics and sickbeds, targeting the limitation that the current pharmacy retail App can only realize door-to-door delivery of medicines.
In August 2015, the leadership of Shenzhen Jiuming Pharmaceutical Co., Ltd. and the fifth affiliated hospital of Zunyi Medical University,Zhuhai proactively realized that the combination of medical treatment and care was a big event concerning the wellbeing of the common folks, which can better change the current status such as lack of medical treatment, lack of medical care, separation of treatment and care, fragmentation of medical treatment and care services and better satisfy the increasing demands of the elderly for medical treatment and care services, Jiuming Medical Rehabilitation Center is located in Zhuhai, the most habitable city of China, one of the “40 national tourist destinations of China”, honored as a newtype “garden city”, “romantic city” and “happy city”, on 268, Gangxia East Road, Doumen district. The Center has been reconstructed on the former site of the old area of the fifth affiliated hospital of Zunyi Medical University,Zhuhai (the People’s Hospital of Doumen district, Zhuhai), occupying 30+ mu and with a construction area of 30,000 plus ㎡. The Center comprises comprehensive large outpatient buildings including department of geriatrics and rehabilitation department, an inpatient department with 350 plus beds and 150 plus VIP endowment beds. Phase I project will be put into operation in December 2016; the whole project will all be officially put into operation by May 2017. After the Center is officially put into operation, it will be deployed with various medical workers such as TCM, Western Medicine, rehabilitation therapists and professional elderly care workers to offer medical treatment, care and rehabilitation services to the elderly patients. With 500+ endowment beds, it will be the largest medical rehabilitation center in Guangdong. Meanwhile, the Center will establish a senile disease research center based on the scientific research strength of Zunyi Medical University and the teaching hospital of the fifth affiliated hospital of Zunyi Medical University,Zhuhai. After the center is put into operation, it’s predicted to create around 300 jobs, which will be of active significance in helping the local government solve problems such as employment and endowment. Meanwhile, the completion of the Center will be a platform for Jiuming Group to repay the society and establish a good public image.
We will continue to uphold the fourword guideline of “diligence, perseverance, integrity, saving” and the operation philosophy of “integrity and mutual benefits, dedication to the society”, and try to build the group into a health industry group integrating scientific technology, industry,trading and logistics together. We are firmly convinced that under the care from all quarters of the society and the great support and assistance of peers in the medical circles, the group will usher in a bright future and share the success with the world.